Navigation Links
Add Value Through Overmolding

MANITOWOC, Wis., Feb. 15, 2012 /PRNewswire-iReach/ -- The more companies learn about overmolding, the more they want to use this special injection-molding technology to add value to their product lines. Not only does it improve functionality and performance, it lowers total production costs—that's pretty rare these days.

So, what is overmolding?

Using a one-shot or two-shot process, a thin layer of TPE (thermoplastic elastomer) is overshot onto the hard plastic substrate of the product. This exterior layer is what creates the soft-touch grip for so many products, like toothbrushes and tool handles. But it has lots of other properties that also add value to the final product—it can reduce shock and vibration, dampen sound, provide electrical insulation, boost chemical/UV resistance, be an effective barrier against oxygen and moisture, and perhaps most importantly, create a wide range of colorful, stylish exteriors that catch the consumer's eye.

More consumers are demanding this look and feel for the personal-care products, tools, electronics, sports equipment, medical devices, etc. they purchase. As a result, overmolding applications continue to expand across a wider range of products. The availability of this technology also gives product engineers more creative freedom in designing attractive and functional products that will keep them on the leading design edge of their markets.

Not every injection-molder can overmold, however; it requires specialized equipment, extensive training, and precise control of multiple variables throughout the production run—even the slightest variations can affect quality, so skilled operators are essential.

Overmolding engineers must have a deep knowledge of material chemistry and know how different types of TPE and substrates interact under varying pressure and temperature conditions. This field of knowledge is also rapidly expanding—suppliers are continuously engineering new blends with expanded characteristics such as chemical resistance, UV resistance, hardness, scratch resistance, clarity, heat resistance, and UL standards. Kaysun Corporation has a vast material science database it has accumulated from hundreds of previous projects and our engineers stay on top of the latest developments in new materials.

It can take some time getting overmolding just right, but it's worth it—this one- or two-step process delivers products of such high quality that the need for some downstream finishing operations is eliminated, which saves time and money and gets products into the marketplace faster.

Of course, this is common knowledge at Kaysun. We have perfected this process through extensive investments in technology and training; this is why top global companies like Rockwell Collins (defense and aerospace) and Smith's Medical (health care) rely on Kaysun.

Learn more about Kaysun's overmolding capabilities by downloading our white paper or contacting us. We're the perfect place to start—and finish—your injection molding project.

Media Contact: Kaysun Corporation Kaysun Corporation, 800-852-9786,

News distributed by PR Newswire iReach:

SOURCE Kaysun Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value
2. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
3. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
4. Industry Executives Finding Value in Shift of Scientific Publications
5. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
6. BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
7. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
8. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
9. Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A
10. Virtual Colonoscopies Show Value for Some Patients, But Polyps Will Be Missed
11. ValueOptions(R) Supports New Hospital-Based Performance Measures to Help Patients Get the Best Treatment for Inpatient and Outpatient Services
Post Your Comments:
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):